Office Action Predictor

Shanghai Shengdi Pharmaceutical Co., LTD.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17414062 HUMAN INTERLEUKIN-2 VARIANT OR DERIVATIVE THEREOF KATAKAM, SUDHAKAR 1658 Final Rejection Jun 15, 2021

Managing Shanghai Shengdi Pharmaceutical Co., LTD.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial